Xoma Royalty CORP Form 4 insider transactions

Bvf Partners L P/Il and 9 others reported changes in beneficial ownership of XOMA Royalty Corp common stock on July 14, 2026.

Maricel Perea Montano, Chief Legal Officer of XOMA Royalty Corp, reported multiple transactions in common stock on July 14, 2026.

Joseph M Limber, a Director of XOMA Royalty Corp, reported multiple transactions in common stock on July 14, 2026.

Barbara Kosacz, a Director of XOMA Royalty Corp, reported multiple transactions in common stock on July 14, 2026.

Jack L Wyszomierski, a Director of XOMA Royalty Corp, reported multiple transactions in common stock on July 14, 2026.

Owen Hughes, Chief Executive Officer and a Director of XOMA Royalty Corp, reported multiple transactions in common stock on July 14, 2026.

Natasha Hernday, a Director of XOMA Royalty Corp, reported multiple transactions in common stock on July 14, 2026.

Bradley Sitko, Chief Investment Officer of XOMA Royalty Corp, reported multiple transactions in common stock on July 14, 2026.

Matthew D Perry, a Director of XOMA Royalty Corp, reported multiple transactions in common stock on July 14, 2026.

Jeffrey Trigilio, Chief Financial Officer of XOMA Royalty Corp, reported multiple transactions in common stock on July 14, 2026.

Heather L Franklin, a Director of XOMA Royalty Corp, reported multiple transactions in common stock on July 14, 2026.

Director Jack L. Wyszomierski of XOMA Royalty Corp. acquired 3,586 restricted stock units, with vesting over 12 months.

Xoma Royalty Corp director Joseph M. Limber reported the acquisition of 3,586 restricted stock units (RSUs) on May 21, 2026.

XOMA Royalty Corp director Natasha Hernday has reported the vesting of 3,586 restricted stock units, with further details on beneficial ownership.

XOMA Royalty Corporation director Matthew Perry has reported the acquisition of 3,586 restricted stock units (RSUs) as part of his compensation.

Heather L. Franklin, a Director at Xoma Royalty Corp, acquired 3,586 restricted stock units (RSUs) on May 21, 2026.

Director Barbara Kosacz of Xoma Royalty Corp has reported the acquisition of 3,586 restricted stock units.

XOMA Royalty Corporation announced a definitive agreement to be acquired by Ligand Pharmaceuticals Incorporated in a merger transaction.

BVF Partners and affiliated entities converted 4,993,000 shares of Series X Convertible Preferred Stock into Common Stock of XOMA Royalty Corp.

CFO Jeffrey Trigilio acquired 11,538 shares of XOMA Royalty Corp common stock through the vesting of performance stock units.

Chief Legal Officer Maricel Montano acquired 3,370 shares of XOMA Royalty Corp common stock through the vesting of performance stock units.

CEO Owen Hughes acquired 10,568 shares of XOMA Royalty Corp common stock through the vesting of performance-based equity awards.

Chief Investment Officer Bradley Sitko acquired 3,737 shares of XOMA Royalty Corp common stock through the vesting of performance-based units.

XOMA Royalty Corp CFO Jeffrey Trigilio acquired 4,000 shares through the vesting of performance stock units and withheld 1,632 shares for tax obligations.

XOMA Royalty Corp. Director Jack L. Wyszomierski exercised options to acquire 3,026 shares of common stock at $11.20 per share.

XOMA Royalty Corp. CEO Owen Hughes received grants of restricted stock units and performance stock units, aligning executive incentives with long-term shareholder value.

XOMA Royalty Corp's Chief Investment Officer, Bradley Sitko, received substantial grants of restricted stock units and performance stock units, aligning his interests with long-term shareholder value.

XOMA Royalty Corp's Chief Financial Officer, Jeffrey Trigilio, was granted 90,000 restricted stock units and 138,462 performance stock units.

XOMA Royalty Corp's Chief Legal Officer, Maricel Perea Montano, received grants of restricted stock units and performance stock units.

XOMA Royalty Corp's Chief Financial Officer, Jeffrey Trigilio, was granted 30,000 performance stock units, aligning executive incentives with shareholder value.